Diagnostic performance of new and classic CSF biomarkers in age-related dementias

Alzheimer’s Disease

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Lancet Neurol.

Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Schöll M, Massarweh G, Soucy JP, Höglund K, Brinkmalm G, Mattsson N, Palmqvist S, Gauthier S, Stomrud E, Zetterberg H, Hansson O, Rosa-Neto P, Blennow K

doi: 10.

Dementia

Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

JAMA Neurol.

Pase MP, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, DeCarli C, Chêne G, Dufouil C, Seshadri S

doi: 10.1001/jamaneurol.

Alzheimer’s DiseaseDementia

A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits

Neurology.

Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Stanzani Maserati M, Devigili G, Eleopra R, Defazio G, Montini F, Baruzzi A, Liguori R

doi: 10.1212/

Parkinson’s Disease

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

Lancet Neurol.

Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU

doi: 10.1016/

COMMENTED

Alzheimer’s Disease

Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults

Neurology.

Sprecher KE, Koscik RL, Carlsson CM, Zetterberg H, Blennow K, Okonkwo OC, Sager MA, Asthana S, Johnson SC, Benca RM, Bendlin BB

doi: 10.1212/

Aging and Cognitive FunctionsDementia

Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population: The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study)

Stroke.

Sigurdsson S, Aspelund T, Kjartansson O, Gudmundsson EF, Jonsdottir MK, Eiriksdottir G, Jonsson PV, van Buchem MA, Gudnason V, Launer LJ

doi: 10.1161/

Aging and Cognitive FunctionsStrokeDementia

Trends in Dementia Incidence in a Birth Cohort Analysis of the Einstein Aging Study

JAMA Neurol.

Derby CA, Katz MJ, Lipton RB, Hall CB

doi: 10.1001/

Aging and Cognitive FunctionsDementia

Potentially inappropriate medication among people with dementia in eight European countries

Age Ageing.

Renom-Guiteras A, Thürmann PA, Miralles R, Klaaßen-Mielke R, Thiem U, Stephan A, Bleijlevens MHC, Jolley D, Leino-Kilpi H, Rahm Hallberg I, Saks K, Soto-Martin M, Zabalegui A, Meyer G; RightTimePlaceCare Consortium

doi: 10.1093/ageing/afx147.

RECOMMENDED

Parkinson’s Disease

CSF and blood biomarkers for Parkinson's disease

Lancet Neurol.

Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P

doi: 10.1016/S1474-4422(19)30024-9.

Related content

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults

Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population: The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study)

Trends in Dementia Incidence in a Birth Cohort Analysis of the Einstein Aging Study

Potentially inappropriate medication among people with dementia in eight European countries

CSF and blood biomarkers for Parkinson's disease